CRP and COVID-19: Compared to COVID‐19 patients without neuro‐PASC, COVID‐19 patients with neuro‐PASC symptoms were on average 2 years older (p = 0.040), more likely female (63.7% vs. 51.0%, p < 0.001), and had lower LDH (p < 0.001), CRP (p = 0.012) and D‐dimer (p < 0.001) measurements.